🔄 Updated 2026 — Reviewed and refreshed with the latest research.
Quick Summary
- Ipamorelin is a pentapeptide GHRP with exceptional selectivity — GH release without cortisol, prolactin, or ghrelin hunger spikes
- Mechanism: Ghrelin receptor (GHSR-1a) agonist → pulsatile GH release
- Who it’s for: Anyone seeking GH optimization, recovery, body composition, longevity
- Key differentiator: Most selective GHRP ever developed — “the clean GHRP”
- Tony’s angle: Pulsatile GH via ipamorelin + mod GRF beats injectable HGH on every practical metric
If you want to boost growth hormone without the cortisol spike, without the hunger surge, and without prolactin issues — ipamorelin is your compound. It’s the most selective growth hormone-releasing peptide ever developed, and it’s the foundation of most peptide protocols involving GH optimization.
How Ipamorelin Works
Ipamorelin is a pentapeptide GHRP that selectively binds to the ghrelin receptor (GHSR-1a) in the pituitary, stimulating a clean pulsatile GH release. Unlike older GHRPs like GHRP-6 or GHRP-2, ipamorelin has exceptional selectivity — it does NOT significantly affect cortisol, prolactin, ACTH, or hunger hormones.
The tony huge Laws of Biochemistry Physics — Law 4: Self-Regulating Systems
Understanding why ipamorelin beats injectable HGH requires Law 4 of the tony huge Laws of Biochemistry Physics: the body fights to maintain homeostasis. Exogenous HGH triggers the pituitary to downregulate natural GH production — the thermostat kicks in. Ipamorelin stimulates your own pituitary to produce GH in natural pulses. You work WITH the self-regulating system rather than forcing an override it will fight back against. The result: long-term axis health preserved, no suppression, superior pulse characteristics.
CJC-1295 (Without DAC): The Perfect Partner
Ipamorelin is almost always paired with Mod GRF 1-29 (cjc-1295 without dac) because they hit independent receptor systems — Law 5 in action:
- Mod GRF 1-29: GHRH receptor → primes pituitary for GH release
- Ipamorelin: Ghrelin receptor → triggers the actual GH pulse
- Combined: 2-10x greater GH release than either alone
Natural Plus Protocol
- Dose: Ipamorelin 100-300 mcg + Mod GRF 1-29 100-200 mcg per injection
- Timing: 2-3x daily: fasted morning, and before sleep (most important doses)
- Route: Subcutaneous, combined in same syringe
- Critical rule: No food 30-60 min before or after — insulin spikes blunt GH release dramatically
- Cycle: Can run long-term given selectivity profile
Benefits Over Time
| Timeframe | What to Expect |
|---|---|
| Week 1-2 | Dramatically improved deep sleep quality — first and most consistent effect |
| Week 4 | IGF-1 increase on bloodwork (30-50% from baseline); body composition shifts beginning |
| Month 3+ | Visible body recomposition, improved skin quality, faster recovery from training |
Bloodwork Monitoring
Per the bloodwork protocol: IGF-1 at 4-6 weeks (target upper quartile for age), fasting glucose quarterly (GH can cause insulin resistance at higher doses), HbA1c for long-term glucose management.
References
- Raun K et al. “Ipamorelin, the first selective growth hormone secretagogue.” Eur J Endocrinol, 1998.
- Nass R et al. “Evidence for acyl-ghrelin modulation of GH release.” J Clin Endocrinol Metab, 2008.
See the complete recovery protocol for how GH optimization integrates into a full system.